Pediatric Imaging

What Imaging Is Best for a Child with Leukocoria or a Suspected Intraocular Mass?

·
What Imaging Is Best for a Child with Leukocoria or a Suspected Intraocular Mass?

A parent brings their 2-year-old to your clinic after noticing a “white glow” in the child’s pupil in a recent flash photograph. On examination, you confirm an abnormal white pupillary reflex, or leukocoria. This finding is an urgent clinical signal, raising immediate concern for an intraocular mass, most critically retinoblastoma. The next decision is which imaging study to order to rapidly and accurately characterize the finding. This article provides a clinical workflow for this specific scenario, guiding you through the American College of Radiology (ACR) recommendations. For a child with leukocoria or a suspected intraocular mass, the ACR rates MRI head and orbits without and with IV contrast as Usually Appropriate.

Who Fits This Clinical Scenario?

This guidance applies to a pediatric patient presenting with leukocoria (an abnormal white pupillary reflex, often called a “cat’s eye reflex”) or an intraocular mass suspected on direct clinical examination, such as fundoscopy. The primary goal of initial imaging in this context is to confirm the presence of a mass, characterize it, and evaluate for local or distant extension, which is critical for diagnosis, staging, and treatment planning.

This workflow is distinct from other pediatric orbital and vision-related presentations. It is crucial to differentiate this scenario from:

  • Traumatic vision loss: A child with a history of trauma requires a different imaging workup focused on detecting fractures, hemorrhage, or foreign bodies.
  • Nontraumatic acute vision loss without papilledema: This presentation suggests etiologies like optic neuritis, which has a different diagnostic pathway.
  • Vision loss with a known history of neurofibromatosis type 1 (NF1): In these cases, the primary concern is often an optic pathway glioma, and imaging protocols are tailored accordingly.

The presence of leukocoria is the key trigger for this specific diagnostic algorithm, as it narrows the differential diagnosis to a set of conditions where precise soft tissue and structural imaging is paramount.

What Diagnoses Are You Working Up in This Scenario?

While several conditions can cause leukocoria, the imaging workup is primarily driven by the need to urgently rule in or rule out retinoblastoma, the most common intraocular malignancy of childhood.

Retinoblastoma: This is the most critical diagnosis to consider. It arises from the retina and can be unilateral or bilateral. Imaging is essential to determine the size and location of the tumor(s), assess for features like calcification, and, most importantly, look for high-risk features such as optic nerve invasion, choroidal invasion, or extraocular extension. The presence of a concurrent intracranial tumor, typically in the pineal gland (trilateral retinoblastoma), must also be evaluated.

Coats Disease: This is a non-hereditary condition characterized by abnormal retinal blood vessel development (telangiectasias), leading to leakage of fluid and lipids into and under the retina. This can cause a total retinal detachment that mimics a solid mass, presenting as leukocoria. Imaging helps differentiate the subretinal exudate of Coats disease from a solid tumor.

Persistent Fetal Vasculature (PFV): Also known as persistent hyperplastic primary vitreous (PHPV), this congenital anomaly results from the failure of the embryonic hyaloid vascular system to regress. It can present with leukocoria, a small eye (microphthalmia), and a cataract. Imaging can identify the characteristic stalk of tissue extending from the optic nerve to the lens.

Toxocariasis: Ocular larva migrans from the nematode Toxocara can cause a granulomatous inflammatory response in the retina or vitreous, which can appear as a white mass and cause leukocoria. The imaging appearance can sometimes mimic retinoblastoma, although clinical history and serology are also key differentiators.

Why Is MRI of the Head and Orbits with Contrast the Recommended Study?

The ACR designates MRI head and orbits without and with IV contrast as Usually Appropriate because it provides the most comprehensive evaluation for the primary diagnostic concerns in this scenario without using ionizing radiation. The same rating applies to MRI orbits without and with IV contrast, but including the head is crucial for a complete workup.

The rationale for this recommendation is multi-faceted:

  • Superior Soft-Tissue Characterization: MRI offers unparalleled detail of the globe’s internal architecture. It can differentiate a solid, enhancing tumor like retinoblastoma from the non-enhancing subretinal exudate of Coats disease or the structural anomalies of PFV.
  • Staging and Risk Stratification: For retinoblastoma, MRI is the cornerstone of staging. It can detect subtle optic nerve thickening and enhancement, indicating tumor invasion—a critical factor for prognosis and treatment. It also assesses for invasion into the choroid, sclera, or orbital soft tissues.
  • Evaluation for Intracranial Disease: Including the entire head in the imaging field is vital to screen for a pineal or other midline intracranial neuroblastic tumor, which occurs in cases of trilateral retinoblastoma. Missing this would be a significant diagnostic error.
  • No Ionizing Radiation: Children, particularly those with genetic predispositions to cancer like hereditary retinoblastoma, are more sensitive to the long-term risks of ionizing radiation. MRI avoids this risk entirely (Radiation Relative Level: O 0 mSv).

Why are alternative studies rated lower?

CT head and orbits with IV contrast is rated as May be appropriate. While CT is highly sensitive for detecting the calcifications commonly seen in retinoblastoma, it has significant drawbacks. Its primary limitation is the use of ionizing radiation (Pediatric RRL: ☢☢☢ 0.3-3 mSv), a major concern in young children. Furthermore, its soft-tissue resolution is inferior to MRI for assessing optic nerve invasion and extraocular extension. CT is typically reserved for cases where MRI is contraindicated or unavailable.

MRI head and orbits without IV contrast is rated Usually not appropriate. Omitting intravenous contrast severely limits the diagnostic utility of the scan. Contrast enhancement is essential for confirming the solid, vascular nature of a tumor, assessing its viability, and detecting subtle optic nerve or choroidal involvement. A non-contrast study is insufficient for a complete and confident evaluation.

What’s Next After MRI? Downstream Workflow

The results of the MRI will dictate immediate and urgent next steps, typically in coordination with a pediatric ophthalmologist and oncologist.

If the MRI is positive for retinoblastoma: An urgent referral to a specialized center with expertise in ocular oncology is mandatory. The MRI findings will be used to stage the disease according to the International Retinoblastoma Staging System. This staging determines the treatment plan, which may include systemic chemotherapy, intra-arterial chemotherapy, focal therapies (laser or cryotherapy), or enucleation (eye removal) for advanced disease.

If the MRI suggests an alternative diagnosis (e.g., Coats disease, PFV): The patient still requires urgent referral to a pediatric ophthalmologist. While not malignant, these conditions can lead to permanent vision loss if not managed appropriately. Treatment may involve laser photocoagulation for Coats disease or surgical intervention for PFV.

If the MRI is negative or indeterminate: A negative MRI is reassuring but may not entirely exclude a very small tumor. The child will require close follow-up and an examination under anesthesia (EUA) by an ophthalmologist for a definitive fundoscopic evaluation. If findings remain indeterminate after MRI and EUA, a multidisciplinary discussion among radiologists, ophthalmologists, and oncologists will guide further management, which could include short-interval follow-up imaging.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for leukocoria requires vigilance to avoid common missteps that can delay diagnosis and impact outcomes.

  • Delaying the workup: Leukocoria in a child should be treated as an emergency until a malignant cause is ruled out. Do not adopt a “watch and wait” approach.
  • Ordering CT as the first-line study: While faster and more accessible, CT exposes the child to radiation and provides less information about tumor extent than MRI. It should only be used when MRI is not a viable option.
  • Omitting the brain from the MRI: Failing to image the entire head risks missing trilateral retinoblastoma. Always specify “head and orbits” in the imaging order.
  • Underestimating the need for sedation: A high-quality MRI in a young child is impossible without general anesthesia or deep sedation. This requires coordination with a pediatric anesthesiology team and should be planned for when ordering the study.

If you encounter any diagnostic uncertainty or confirm a finding suspicious for retinoblastoma, immediate consultation with a pediatric ophthalmologist is the critical next step.

Related ACR Topics and Tools

The ACR Appropriateness Criteria are a powerful resource for evidence-based imaging decisions. For a broader view of related pediatric vision loss scenarios, or to access tools for study selection and patient communication, the following GigHz resources are available.

Frequently Asked Questions

Why is MRI preferred over CT if CT is better at detecting calcifications in retinoblastoma?

While CT is excellent for identifying calcification, MRI is superior for the most critical staging questions: assessing optic nerve invasion, choroidal involvement, and extraocular extension. Furthermore, MRI avoids the use of ionizing radiation, which is a significant advantage in children who may have a genetic predisposition to cancer. The superior soft-tissue contrast and lack of radiation make MRI the preferred first-line study.

Does every child with leukocoria need an MRI scan?

Yes, leukocoria is a red flag for serious intraocular pathology, most importantly retinoblastoma. A prompt and thorough evaluation is mandatory. An MRI of the head and orbits is the cornerstone of this evaluation to confirm a diagnosis, rule out malignancy, and provide essential staging information that guides immediate treatment.

Why is intravenous contrast required for this MRI?

Intravenous contrast is crucial for characterizing an intraocular mass. In retinoblastoma, the solid tumor components will typically enhance, helping to differentiate it from non-enhancing fluid or exudate seen in mimickers like Coats disease. Contrast also highlights potential areas of optic nerve or choroidal invasion, which are critical prognostic factors that are difficult or impossible to assess on non-contrast images.

What if my facility lacks immediate access to pediatric MRI with anesthesia?

This is a time-sensitive diagnosis. If you cannot obtain a high-quality pediatric MRI with the necessary anesthesia support in a timely manner at your institution, the patient should be urgently transferred to a tertiary care pediatric center that has these capabilities and an on-site pediatric ophthalmology/oncology team. Delaying the diagnosis can adversely affect the child’s vision and survival.

Is ultrasound useful in the workup of leukocoria?

Ocular ultrasound is an excellent initial tool often used by ophthalmologists. It is fast, uses no radiation, and can confirm the presence of an intraocular mass and calcifications. However, it cannot evaluate for optic nerve invasion behind the globe or screen for intracranial disease. Therefore, while it’s a valuable complementary study, it does not replace the need for a comprehensive MRI for full staging.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026